Calidi Biotherapeutics (CLDI) Stock Chart & Stock Price History $0.60 +0.01 (+0.97%) As of 03:11 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Calidi Biotherapeutics Stock Price Performance The Calidi Biotherapeutics (CLDI) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 61.05%, with a year-to-date return of -48.17%. In the past month, the stock has increased 141.30%, reflecting recent market activity. As of the latest close, Calidi Biotherapeutics traded at $0.59 with a market cap of $21.44 million and volume of 1.82 million shares. Receive CLDI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Calidi Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+1.86%1 Month Performance+141.30%3 Month Performance+19.65%Year-To-Date Performance-48.17%1 Year Performance-61.05% CLDI Stock Chart for Monday, August, 4, 2025 CLDI Chart by TradingView Calidi Biotherapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/01/2025$0.60$0.59-0.92%$0.61$0.531.82 million shs$21.44 million07/31/2025$0.59$0.60+1.83%$0.63$0.592.36 million shs$21.64 million07/30/2025$0.63$0.59-7.38%$0.63$0.565.13 million shs$21.25 million07/29/2025$0.55$0.63+14.94%$0.91$0.60178.37 million shs$22.94 million07/28/2025$0.73$0.55-24.71%$0.65$0.504.57 million shs$19.96 million07/25/2025$0.77$0.73-5.43%$0.74$0.682.59 million shs$26.51 million07/24/2025$0.74$0.77+4.42%$0.82$0.752.23 million shs$28.04 million07/23/2025$0.70$0.74+6.21%$0.77$0.712.05 million shs$26.85 million07/22/2025$0.71$0.70-2.23%$0.74$0.652.01 million shs$25.91 million07/21/2025$0.59$0.71+19.93%$0.76$0.605.99 million shs$25.86 million Get the Latest News and Ratings for CLDI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Calidi Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/18/2025$0.62$0.59-3.62%$0.64$0.572.55 million shs$21.56 million07/17/2025$0.63$0.62-2.58%$0.64$0.573.24 million shs$22.37 million07/16/2025$0.57$0.63+10.52%$0.71$0.604.48 million shs$22.96 million07/15/2025$0.58$0.57-1.21%$0.57$0.474.99 million shs$20.78 million07/14/2025$0.76$0.58-23.82%$0.71$0.547.53 million shs$21.03 million07/11/2025$1.00$0.76-23.85%$0.96$0.7014.58 million shs$24.16 million07/10/2025$0.70$1.00+42.57%$1.10$0.66116.33 million shs$31.73 million07/09/2025$0.34$0.70+108.96%$1.60$0.64618.72 million shs$22.26 million07/08/2025$0.24$0.34+39.47%$0.34$0.2427.41 million shs$10.65 million07/07/2025$0.25$0.24-2.75%$0.26$0.221.39 million shs$7.64 million07/04/2025$0.25$0.25$0.25$0.23551,055 shs$7.85 million07/03/2025$0.23$0.25+5.60%$0.25$0.23551,055 shs$7.85 million Related Companies Metagenomi Stock Chart eXoZymes Stock Chart Whitehawk Therapeutics Stock Chart Vaxart Stock Chart ESSA Pharma Stock Chart Alto Neuroscience Stock Chart Maxpro Capital Acquisition Stock Chart BeyondSpring Stock Chart Elutia Stock Chart Surrozen Stock Chart Receive CLDI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Calidi Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:CLDI) was last updated on 8/4/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredA grave, grave error.Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history. But one ...Porter & Company | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredOut with the old (A.I.) - In with the new (E.I.)One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Calidi Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Calidi Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
